Réaction #77834

ord-548d4312cc224e57adc1d3f3ab1ca060

Solvants

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Lavagethe solution was washed with 1N HCl
  2. 2
    SéchageThe EtOAc was dried
  3. 3
    Filtrationfiltered
  4. 4
    Concentrationconcentrated
  5. 5
    AutreReverse phase HPLC purification (gradient elution, water/acetonitrile/TFA) of the resulting residue

Mode opératoire

N-(cis)-{2-[(aminoacetyl)amino]cyclohexyl}-4-(aminosulfonyl)benzamide hydrogen bromide, (61b), (100 mg) was dissolved in DMF (3 mL) prior to the addition of 4-methylmorpholine (0.13 mL) and 2-trifluoromethylphenyl isocyanate (0.05 mL). After stirring overnight, EtOAc was added and the solution was washed with 1N HCl. The EtOAc was dried, filtered, and concentrated. Reverse phase HPLC purification (gradient elution, water/acetonitrile/TFA) of the resulting residue provided the title benzamide (50 mg). MS found: (M+Na)+=564.3.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US06706712B2uspto-grants-2004_03